{"title":"青少年mRNA疫苗相关心肌炎2例报告","authors":"C. Mc","doi":"10.23880/jidtm-16000160","DOIUrl":null,"url":null,"abstract":"Myopericarditis related to mRNA SARS CoV2 vaccines in adolescents is a rare side effect and currently reported after the second dose of Pfizer-BioNTech dose. Here we describe two cases without severity signs or complications after inpatient follow-up and ambulatory treatment. Although treatment is still controversial a good prognosis and non-sequela after injury is expected. A correct approach and suspect diagnosis of myocarditis in children must be excluded after compatible symptoms and recent COVID-19 vaccination and discarding other potential infections.","PeriodicalId":402204,"journal":{"name":"Journal of Infectious Diseases & Travel Medicine","volume":"21 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Myopericarditis Associated to mRNA Vaccine in Adolescents: Report of Two Cases\",\"authors\":\"C. Mc\",\"doi\":\"10.23880/jidtm-16000160\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Myopericarditis related to mRNA SARS CoV2 vaccines in adolescents is a rare side effect and currently reported after the second dose of Pfizer-BioNTech dose. Here we describe two cases without severity signs or complications after inpatient follow-up and ambulatory treatment. Although treatment is still controversial a good prognosis and non-sequela after injury is expected. A correct approach and suspect diagnosis of myocarditis in children must be excluded after compatible symptoms and recent COVID-19 vaccination and discarding other potential infections.\",\"PeriodicalId\":402204,\"journal\":{\"name\":\"Journal of Infectious Diseases & Travel Medicine\",\"volume\":\"21 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Infectious Diseases & Travel Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23880/jidtm-16000160\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infectious Diseases & Travel Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23880/jidtm-16000160","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Myopericarditis Associated to mRNA Vaccine in Adolescents: Report of Two Cases
Myopericarditis related to mRNA SARS CoV2 vaccines in adolescents is a rare side effect and currently reported after the second dose of Pfizer-BioNTech dose. Here we describe two cases without severity signs or complications after inpatient follow-up and ambulatory treatment. Although treatment is still controversial a good prognosis and non-sequela after injury is expected. A correct approach and suspect diagnosis of myocarditis in children must be excluded after compatible symptoms and recent COVID-19 vaccination and discarding other potential infections.